SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Burt AD, MacSween RNM, Peters TJ, Simpson KJ. Non-alcoholic fatty liver: causes and complications. In: McIntyreN, et al., eds. Oxford Textbok of Clinical Hepatology. Vol 2, Ed 1. Oxford: Oxford University Press, 1991:865871.
  • 2
    Zimmerman HJ, Ishak KG. Non-alcoholic steatohepatitis and other forms of pseudoalcoholic liver disease. In: HallP, ed. Alcoholic Liver Disease: Pathology and Pathogenesis. 2nd ed. London: Edward Arnold. 1994;175198.
  • 3
    Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107:11031109.MEDLINE
  • 4
    Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11:7480.MEDLINE
  • 5
    Fiatarone JR, Coverdale SA, Batey RG, Farrell GC. Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. J Gastroenterol Hepatol 1991; 6:585590.MEDLINE
  • 6
    Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12:11061110.MEDLINE
  • 7
    Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, et al. Ursodeoxycholic acid or clofibrate in the treatment of non–alcohol-induced steatohepatitis: a pilot study. Hepatology 1996; 23:14641467.MEDLINE
  • 8
    Ludwig J, Viggiano TR, McGill DB, Ott BJ. Non-alcoholic steatohepatitis. Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 1980; 55:434438.MEDLINE
  • 9
    Eriksson S, Eriksson KF, Bondesson L. Non-alcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986; 220:8388.MEDLINE
  • 10
    Itoh S, Yougel T, Kawagoe K. Comparison between non-alcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987; 82:650654.MEDLINE
  • 11
    Ingelman-Sundberg M, Ekström G, Tindberg N. Lipid peroxidation dependent on ethanol-inducible cytochrome P-450 from rat liver. Adv Biophys 1988; 71:4347.
  • 12
    Takahashi T, Lasker JM, Rosman AS, Lieber CS. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993; 17:236245.MEDLINE
  • 13
    Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 1989; 10:437446.MEDLINE
  • 14
    Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliasson E, Clot P, Albano E. Ethanol-inducible cytochrome P450 2E1: genetic polymorphism, regulation and possible role in the etiology of alcohol-induced liver disease. Alcohol 1993; 10:447452.MEDLINE
  • 15
    Persson JO, Terelius Y, Ingelman-Sundberg M. Cytochrome P450 dependent formation of reactive oxygen radicals: isoenzyme-specific inhibition of P450 mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 1990; 20:887900.MEDLINE
  • 16
    Ekström G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989; 38:13131319.MEDLINE
  • 17
    Dai Y, Rashba-Step J, Cederbaum AI. Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and the production of reactive oxygen intermediates. Biochemistry 1993; 32:69286937.MEDLINE
  • 18
    Gorsky LD, Koop DR, Coon MJ. On the stoichiometry of the oxidase and monoxygenase reactions catalysed by liver microsomal cytochrome P450. J Biol Chem 1984; 259:68126817.MEDLINE
  • 19
    Koop DR. Oxidative and reductive metabolism by cytochrome P-450 2E1. FASEB J 1992; 6:724730.MEDLINE
  • 20
    Bühler R, Lindros KO, von Boguslawsky K, Kärkkäinen P, Mäkinen J, Ingelman-Sundberg M. Perivenous expression of ethanol-inducible cytochrome P450IIE1 in livers from alcoholics and ethanol-fed rats. Alcohol Alcohol 1991; 1:311315.
  • 21
    Favreau LV, Malchoff DM, Mole JE, Schenkman JB. Responses to insulin by two forms of rat hepatic microsomal cytochrome P-450 that undergo major (RLM6) and minor (RLM5b) elevations in diabetics. J Biol Chem 1987; 262:1431914326.MEDLINE
  • 22
    Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB. Induction of cytochrome P450IIE1 in the obese overfed rat. Mol Pharmacol 1991; 39:275280.MEDLINE
  • 23
    Dong Z, Hong J, Ma Q, Li D, Bullock J, Gonzalez FJ, Park SS, et al. Mechanism of induction of cytochrome P450ac (P450j) in chemically-induced and spontaneously diabetic rats. Arch Biochem Biophys 1988; 263:2935.MEDLINE
  • 24
    Shaw PM, Barnes TS, Cameron D, Engeset J, Melvin WT, Omar G, Petrie JC, et al. Purification and characterization of an anti-convulsant–induced human cytochrome P-450 catalysing cyclosporin metabolism. Biochem J 1989; 263:653663.MEDLINE
  • 25
    Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat model of hepatic steatosis with inflammation. Gastroenterology 1996; 111:16451653.MEDLINE
  • 26
    Ingelman-Sundberg M, Johansson I, Penttilä KE, Glaumann H, Lindros KO. Centrilobular expression of ethanol-inducible cytochrome P450 (IIE1) in rat liver. Biochem Biophys Res Commun 1988; 157:5560.MEDLINE
  • 27
    George J, Murray M, Byth K, Farrell GC. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995; 21:120128.MEDLINE
  • 28
    Morimoto M, Hajbjörk A, Wan Y-JY, Fu PC, Clot P, Albano E, Ingelman-Sundberg M, et al. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 1995; 21:16101617.MEDLINE
  • 29
    Popper H, Lieber CS. Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 1980; 98:695716.MEDLINE
  • 30
    French SW, Wong K, Albano E, Hagbjork AL, Ingelman-Sundberg M. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 1993; 58:6175.MEDLINE
  • 31
    Leclercq I, Horsmans Y, Desager, Pauwels S, Geubel AP. Influence of diet on liver volume and cytochrome P-450 activities in human non-alcoholic fatty liver [Abstract]. Hepatology 1996; 24:A737.
  • 32
    Pinto HC, Felipe P, Bapista A, Fernandes A, Camilo E, Ramalho F, Moura MC. Hepatic steatosis and lipid peroxidation in human chronic liver diseases [Abstract]. Hepatology 1996; 24:A740.
  • 33
    Sharer JE, Wrighton SA. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metab Dispos 1996; 24(Suppl 4:487494.MEDLINE